Compounds > staurosporine aglycone
Page last updated: 2024-10-29

staurosporine aglycone and Liver Neoplasms

staurosporine aglycone has been researched along with Liver Neoplasms in 2 studies

staurosporine aglycone: metabolite from culture broth of Nocardiopsis sp.; a neurotrophin antag; inhibits BDNF TrkB receptor

Liver Neoplasms: Tumors or cancer of the LIVER.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nakayama, T2
Hashimoto, Y2
Kaneko, Y2
Yoshida, M1
Beppu, T1
Ohmi, K1
Yamashita, S1
Nonomura, Y1
Kurokawa, K2

Other Studies

2 other studies available for staurosporine aglycone and Liver Neoplasms

ArticleYear
K252a: a new blocker of the cell-cycle at G1 phase in a human hepatoma cell line.
    Experientia, 1993, Oct-15, Volume: 49, Issue:10

    Topics: Carbazoles; Carcinoma, Hepatocellular; Cell Division; DNA; Flow Cytometry; G1 Phase; Gene Expression

1993
K252a inhibits the phosphorylation of pRb without changing the levels of G1 cyclins and Cdk2 protein in human hepatoma cells.
    Biochemical and biophysical research communications, 1996, Jul-05, Volume: 224, Issue:1

    Topics: Carbazoles; Carcinoma, Hepatocellular; CDC2-CDC28 Kinases; Cell Cycle; Cell Line; Cyclin D1; Cyclin-

1996